The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Spasmalvex 60 mg/300 mg, soft capsules



Laboratoires Galeniques VerninPA1927/002/001

Main Information

Trade NameSpasmalvex 60 mg/300 mg, soft capsules
Active SubstancesALVERINE CITRATE
Simeticone
Dosage FormCapsule, soft
Licence HolderLaboratoires Galeniques Vernin
Licence NumberPA1927/002/001

Group Information

ATC CodeA03AX58 alverine, combinations

Status

License statusAuthorised
Licence Issued12/03/2021
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back